88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Soonr Health Officially Launches in the U.S. with Connected At-Home Fertility Tracking for Couples With the launch of Surearly SMART on Amazon, Soonr Health now offers couples connected at-home ovulation and hormone testing, the first device in an expanding ecosystem built around dyadic health. ... 2026-06-04T Biotechnology Health Care/Hospital Household/Consumer/Cosmetics
Stronger Together, Shaping the Future \| WuXi XDC and BioDlink Successfully Concluded 2026 Open Day WuXi XDC and BioDlink jointly hosted the 2026 Open Day, marking their first flagship customer-facing event following the strategic integration. The event brought together biotech customers, industry ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational Next-Generation Peptide CRDMO Solutions Enabled by a Green and Intelligent Platform for Empowering Global Innovative Drug Development ... 2026-06-04T Chemical Health Care/Hospital Medical/Pharmaceuticals
Zhongchao Inc. Announces 1-for-31 Share Consolidation SHANGHAI , June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with ... 2026-06-04T Banking/Financial Service Health Care/Hospital
Innovative Drug Update \| Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10 SHENZHEN, China , June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin ® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast ... 2026-06-04T Health Care/Hospital Medical/Pharmaceuticals
Waterdrop Inc. to Report First Quarter 2026 Financial Results on June 16, 2026 BEIJING , June 4, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service ... 2026-06-04T Banking/Financial Service Computer/Electronics Health Care/Hospital
World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA SAN FRANCISCO and SUZHOU, China , June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma GUANGZHOU, China , June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
111, Inc. Announces First Quarter 2026 Unaudited Financial Results Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year ... 2026-06-04T Health Care/Hospital Medical/Pharmaceuticals Retail

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved